Acadia Pharma (ACAD) Misses Q1 EPS by 13c
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $25.97 +3.06%
Revenue Growth %: +11.8%
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
CRMT, More
Revenue Growth %: +11.8%
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q1 EPS of ($0.40), $0.13 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $4 thousand versus the consensus estimate of $80 thousand.
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Isabella Bank added to Russell 2000 index after Nasdaq listing
- Berenberg Starts Brooks Macdonald Group PLC (BRK:LN) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
